CCCC vs IT · rev $35.6M vs P/E 16, rev $6.27B
C4 Therapeutics Inc (CCCC) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
CCCC currently screens at market cap $425.7M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the CCCC and IT stock pages for the full models.
Not investment advice.